United States· US:22840-5609_36ac182a-ff48-50a9-e063-6394a90aa917
Botrytis cinerea
A medicinal product containing botrytis cinerea, registered in United States by Greer Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BOTRYTIS CINEREA
- Manufacturer
- Greer Laboratories, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11228405609210 mL in 1 VIAL, MULTI-DOSE (22840-5609-2)
- ndc11228405609450 mL in 1 VIAL, MULTI-DOSE (22840-5609-4)
- ndc1122840560955 mL in 1 BOTTLE, DROPPER (22840-5609-5)
- ndc1122840-5609-2
- ndc1122840-5609-4
- ndc1122840-5609-5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Botrytis cinerea in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyPrick-Testlösung Botrytis CinereaAllergopharma Gmbh & Co. Kg
- SwitzerlandPrick-Test Botrytis cinerea, PricktestlösungDermapharm AG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Prick-Testlösung Botrytis Cinerea, Provokations-Testlösung Botrytis Cinerea
- Hungary · Alyostal Prick Penészgombák Allergén Kivonatot Tartalmazó Oldatok, Allergiás Betegségek Diagnosztizálásában Használatos Prick Tesztek Végzésére, Staloral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8697ddfc-844f-4945-80a5-923b765b32d4 GET /v1/drugs/8697ddfc-844f-4945-80a5-923b765b32d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS",
"source": "ndc",
"strength": ".025",
"substance": "BOTRYTIS CINEREA",
"productndc": "22840-5609",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "g/mL",
"application_number": "BLA101833",
"marketing_category": "BLA"
}See everything about botrytis cinerea.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.